BioArctic Q1 Results: Strong Leqembi Sales Offset by FDA Delay and Swedish Rejection
BioArctic secured a EUR 20M milestone payment as Leqembi sales topped EUR 500M, despite an FDA review delay for its subcutaneous formulation.
Read the full storyOn May 19, 2026, Aedifica's EPRA Earnings rose by 19% to €74.5 million in Q1. The company also acquired 80% of Cofinimmo shares, with the legal merger expected to take effect on July 1, 2026. Additionally, S&P upgraded Aedifica's credit rating from BBB to BBB+ with a stable outlook.
BioArctic secured a EUR 20M milestone payment as Leqembi sales topped EUR 500M, despite an FDA review delay for its subcutaneous formulation.
Read the full storyThe offshore wind service provider reported revenue of EUR 125 million, driven by increased contracted activity and the expansion of its operating fleet.
New Zealand-based Argosy Property Limited conducted its fiscal Q4 2026 earnings call to discuss annual financial results and the future outlook for its portfolio.
Euronext posted its eighth consecutive quarter of double-digit growth with €528.50 million in revenue, driven by robust trading and a solid balance sheet.
The healthcare REIT reported EPRA earnings of €74.5 million and secured an S&P credit rating upgrade to BBB+ following its 80% stake acquisition in Cofinimmo.